High likelihood of actionable pathogenic variant detection in breast cancer genes in women with very early onset breast cancer.
Dafydd Gareth EvansElke Maria van VeenHelen J ByersSarah J EvansGeorge Joseph BurghelEmma Roisin WoodwardElaine F HarknessDiana M EcclesStephanie L Greville-HaygateJamie M EllingfordNaomi L BowersMarta PereiraAndrew J WallaceSasha J HowellAnthony HowellFiona LallooWilliam G NewmanMiriam Jane SmithPublished in: Journal of medical genetics (2021)
The rates of BRCA1, BRCA2 and TP53 PVs are high in very early onset breast cancer, with limited benefit from testing of additional breast cancer-associated genes.